Back to search
FDAFDA · Food and drugs·Recall number Z-0335-2013

Superstat Modified Collagen Hemostatic Sponge, 85mm x 85mm Pledget, 3.0%, Part# 9300-30. For use when hemostasis is desired along suture lines, in diffusely bleeding sites, in incisions, dissections, and around arterial or venous anastomoses. Indicated in oozing bleeding, either capillary or venous, in almost all types of incisions or wounds, and as an adjunct to conventional closure techniques

Published November 28, 2012 · Recall initiated: October 24, 2012

Summary

FDA records medical device Class II recall Z-0335-2013, published November 28, 2012 and initiated October 24, 2012. Recalling firm: Superstat Corp; Status: Terminated; Reported quantity: 26,422 units; Lot: Lot# R1018P, S1503P, S2802P, SSN03P . Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The recall was initiated because Superstat Corporation has confirmed that no documentation are available to verify that quarterly dose sterility audits were performed for the Superstat Modified Collagen Hemostatic Sponge.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Superstat Corp
Distributor
Worldwide Distribution - USA (nationwide) and the countries of Saudi Arabia, Thailand, Mexico, Canada, Pakistan, Israel, Greece, Serbia, Canda, Isle of Man, Nova Scotia, and Singapore.
Lot
Lot# R1018P, S1503P, S2802P, SSN03P .
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Superstat Modified Collagen Hemostatic Sponge, 85mm x 85mm Pledget, 3.0%, Part# 9300-30. For use when hemostasis is desired along suture lines, in diffusely bleeding sites, in incisions, dissections, and around arterial or venous anastomoses. Indicated in oozing bleeding, either capillary or venous, in almost all types of incisions or wounds, and as an adjunct to conventional closure techniques recalled?

Yes. FDA published recall Z-0335-2013 on November 28, 2012. Reported hazard: The recall was initiated because Superstat Corporation has confirmed that no documentation are available to verify that quarterly dose sterility audits were performed for the Superstat Modified Collagen Hemostatic Sponge.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone